Connect with us

Hi, what are you looking for?

Stock

Nissan’s Ariya electric SUV sales delayed due to COVID-19, chip shortage

Stock Markets25 minutes ago (Jun 04, 2021 01:45AM ET)

(C) Reuters. FILE PHOTO: A Nissan Ariya electric vehicle (EV) is seen displayed at the Dongfeng Nissan booth during a media day for the Auto Shanghai show in Shanghai, China April 19, 2021. REUTERS/Aly Song

TOKYO (Reuters) – Availability of Nissan (OTC:NSANY) Motor Co’s Ariya, a new electric SUV, will be delayed due to the coronavirus pandemic and a global shortage of chips, a senior executive at the carmaker said on Friday.

Nissan announced last year that it had planned to begin sales of the Ariya in Japan from mid-2021. But the rollout of the limited model in Japan has been pushed to “this winter,” executive vice president Asako Hoshino, told reporters.

“Sales in the United States and Europe will typically come around two months later,” Hoshino said. She said she expects the model to be sold around tens of thousands in the first year of sales, with the highest demand in Europe.

“I think in Europe, (the Ariya) will of course contribute to (the overall) unit sales,” Hoshino also said, when asked what the significance of the model is to the carmaker.

The Ariya is Nissan’s first brand-new EV in almost a decade after the Leaf hatchback, which made its mark as the world’s first mass-market electric vehicle.

The electric SUV will also be sold in China but no specific timeline has been disclosed yet.

Nissan’s Ariya electric SUV sales delayed due to COVID-19, chip shortage

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Stock

Stock Markets25 minutes ago (Jul 16, 2021 05:46PM ET) (C) Reuters. FILE PHOTO: Johnson & Johnson’s Neutrogena Cool Dry Sport sunscreen, which is part...

Tech

Builders, creators and developers, this one’s for you! TechCrunch has always been about discovering fresh solutions and shining the light on exciting, new products...

Disclaimer: Wisegazette.com it's managers and its employees (collectively "The Company") do not make any guarantee or warranty about what is advertised or above. Information provided by this website is for research purposes only and should not be considered as personalized financial or health advice. Copyright © 2021 Wise Gazette. All Rights Reserved